静脉丙种球蛋白联合血小板输注、利伐沙班治疗肝素诱导的危重血小板减少症1例

黄河; 林颖; 姚荣欣; 何牧卿; 林晓骥

doi:10.24920/003462

Your Location：

Home >

Browse articles >

静脉丙种球蛋白联合血小板输注、利伐沙班治疗肝素诱导的危重血小板减少症1例

中国医学科学杂志（英文版） 2019年34卷第1期页码：60-64

Case Reports | Updated：2024-04-10

- 静脉丙种球蛋白联合血小板输注、利伐沙班治疗肝素诱导的危重血小板减少症1例
- Affiliations：
  
  Department of Hematology, The 2nd Affiliated Hospital & Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, China
- Author bio：
  
  * Tel: 86-577-88002716; E-mail: linxiaoji321@163.com
- Funds：
- DOI：10.24920/003462
  中图分类号：
- 收稿日期：2018-05-22，
  
  修回日期：2019-02-22，
  
  网络出版日期：2019-03-30，
  
  纸质出版日期：2019-03-30
- Accepted：
Scan QR Code
黄河, 林颖, 姚荣欣, 等. 静脉丙种球蛋白联合血小板输注、利伐沙班治疗肝素诱导的危重血小板减少症1例[J]. 中国医学科学杂志（英文版）, 2019,34(1):60-64.

Huang He, Lin Ying, Yao Rongxin, et al. Successful Treatment of Severe Heparin-induced Thrombocytopenia with Intravenous Immunoglobulin, Platelet Transfusion and Rivaroxaban: A Case Report[J]. Chinese medical sciences journal, 2019, 34(1): 60-64.
黄河, 林颖, 姚荣欣, 等. 静脉丙种球蛋白联合血小板输注、利伐沙班治疗肝素诱导的危重血小板减少症1例[J]. 中国医学科学杂志（英文版）, 2019,34(1):60-64. DOI： 10.24920/003462.

Huang He, Lin Ying, Yao Rongxin, et al. Successful Treatment of Severe Heparin-induced Thrombocytopenia with Intravenous Immunoglobulin, Platelet Transfusion and Rivaroxaban: A Case Report[J]. Chinese medical sciences journal, 2019, 34(1): 60-64. DOI： 10.24920/003462.

摘要

肝素诱导血小板减少症是指应用肝素过程中，以血小板减少，常合并静脉血栓发生为主要表现的疾病，是临床上肝素少见而严重的不良反应。我们使用静脉丙种球蛋白、血小板输注及口服抗凝药利伐沙班成功治疗了1例同时存在血栓与出血表现，肝素诱导的血小板减少症患者。通过对此病例的治疗，我们认为静脉丙种球蛋白输注对危急重肝素诱导的血小板减少症的转归起到关键作用，一方面它避免了血栓的进一步形成；另一方面保证了血小板输注与利伐沙班治疗的有效性。因此，对于危急重肝素诱导的血小板减少症患者，静脉丙种球蛋白输注是一种有效而较优的治疗措施。

Abstract

Heparin-induced thrombocytopenia (HIT) is a relatively infrequent complication of heparin administration. HIT can cause devastating thrombosis

making it one of the most serious adverse drug reactions encountered in clinical practice. We successfully treated a case of severe HIT presenting with thrombosis and life-threatening bleeding complications with intravenous immunoglobulin (IVIG)

platelet transfusion and oral anticoagulant Rivaroxaban. In this case

we considered that IVIG played the most important role by preventing further thrombosis

increasing the platelet count

and ensuring the efficacy of Rivaroxaban. We therefore suggest that IVIG might be the optimal treatment for patients with this urgent condition.

关键词

Keywords

references

Visentin GP , Ford SE , Scott JP , et al . Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells . J Clin Invest 1994 ; 93 ( 1 ): 81 - 8 . doi: 10.1172/JCI116987 10.1172.JCI116987 . DOI: 10.1172/JCI116987 http://doi.org/10.1172/JCI116987 http://www.jci.org/articles/view/116987 http://www.jci.org/articles/view/116987

Warkentin TE . Clinical presentation of heparin-induced thrombocytopenia . Semin Hematol 1998 ; 35 ( 4 Suppl 5):9-16; discussion 35-6. DOI: 10.1016/S0145-2126(98)00095-2 http://doi.org/10.1016/S0145-2126(98)00095-2 http://europepmc.org/abstract/MED/9855179 http://europepmc.org/abstract/MED/9855179

Greinacher A , Selleng S . How I evaluate and treat thrombocytopenia in the intensive care unit patient . Blood 2016 ; 128 ( 26 ): 3032 - 42 . doi: 10.1182/blood-2016-09-693655 10.1182.blood-2016-09-693655 . DOI: 10.1182/blood-2016-09-693655 http://doi.org/10.1182/blood-2016-09-693655 http://www.ncbi.nlm.nih.gov/pubmed/28034871 http://www.ncbi.nlm.nih.gov/pubmed/28034871

Cuker A , Gimotty PA , Crowther MA , et al . Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis . Blood 2012 ; 120 ( 20 ): 4160 - 7 . doi: 10.1182/blood-2012-07-443051 10.1182.blood-2012-07-443051 . DOI: 10.1182/blood-2012-07-443051 http://doi.org/10.1182/blood-2012-07-443051 http://www.bloodjournal.org/cgi/doi/10.1182/blood-2012-07-443051 http://www.bloodjournal.org/cgi/doi/10.1182/blood-2012-07-443051

Khandelwal S , Arepally GM . Immune pathogenesis of heparin-induced thrombocytopenia . Thromb Haemost 2016 ; 116 ( 5 ): 792 - 8 . doi: 10.1160/TH16-01-0074 10.1160.TH16-01-0074 . DOI: 10.1160/TH16-01-0074 http://doi.org/10.1160/TH16-01-0074 http://www.thieme-connect.de/DOI/DOI?10.1160/TH16-01-0074 http://www.thieme-connect.de/DOI/DOI?10.1160/TH16-01-0074

Greinacher A , Farner B , Kroll H , et al . Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients . Thromb Haemost 2005 ; 94 ( 1 ): 132 - 5 . doi: 10.1160/TH04-12-0825 10.1160.TH04-12-0825 . DOI: 10.1160/TH04-12-0825 http://doi.org/10.1160/TH04-12-0825 http://www.thieme-connect.de/DOI/DOI?10.1160/TH04-12-0825 http://www.thieme-connect.de/DOI/DOI?10.1160/TH04-12-0825

Warkentin TE , Makris M , Jay RM , et al . A spontaneous prothrombotic disorder resembling heparin-induced thrombocytopenia . Am J Med 2008 ; 121 ( 7 ): 632 - 6 . doi: 10.1016/j.amjmed.2008.03.012 10.1016.j.amjmed.2008.03.012 . DOI: 10.1016/j.amjmed.2008.03.012 http://doi.org/10.1016/j.amjmed.2008.03.012 https://linkinghub.elsevier.com/retrieve/pii/S0002934308002611 https://linkinghub.elsevier.com/retrieve/pii/S0002934308002611

Jay RM , Warkentin TE . Fatal heparin-induced thrombocytopenia (HIT) during warfarin thromboprophylaxis following orthopedic surgery: another example of ‘spontaneous’ HIT? J Thromb Haemost 2008 ; 6 ( 9 ): 1598 - 600 . doi: 10.1111/j.1538-7836.2008.03040.x 10.1111.j.1538-7836.2008.03040.x . DOI: 10.1111/j.1538-7836.2008.03040.x http://doi.org/10.1111/j.1538-7836.2008.03040.x http://blackwell-synergy.com/doi/abs/10.1111/jth.2008.6.issue-9 http://blackwell-synergy.com/doi/abs/10.1111/jth.2008.6.issue-9

Warkentin TE , Basciano PA , Knopman J , et al . Spontaneous heparin-induced thrombocytopenia syndrome: 2 new cases and a proposal for defining this disorder . Blood 2014 ; 123 ( 23 ): 3651 - 4 . doi: 10.1182/blood-2014-01-549741 10.1182.blood-2014-01-549741 . DOI: 10.1182/blood-2014-01-549741 http://doi.org/10.1182/blood-2014-01-549741 http://www.bloodjournal.org/cgi/doi/10.1182/blood-2014-01-549741 http://www.bloodjournal.org/cgi/doi/10.1182/blood-2014-01-549741

Pruthi RK , Daniels PR , Nambudiri GS , et al . Heparin-induced thrombocytopenia (HIT) during postoperative warfarin thromboprophylaxis: a second example of postorthopedic surgery ‘spontaneous’ HIT . J Thromb Haemost 2009 ; 7 ( 3 ): 499 - 501 . doi: 10.1111/j.1538-7836.2008.03263.x 10.1111.j.1538-7836.2008.03263.x . DOI: 10.1111/j.1538-7836.2008.03263.x http://doi.org/10.1111/j.1538-7836.2008.03263.x http://blackwell-synergy.com/doi/abs/10.1111/jth.2009.7.issue-3 http://blackwell-synergy.com/doi/abs/10.1111/jth.2009.7.issue-3

Ketha S , Smithedajkul P , Vella A , et al . Adrenal haemorrhage due to heparin-induced thrombocytopenia . Thromb Haemost 2013 ; 109 ( 4 ): 669 - 75 . doi: 10.1160/TH12-11-0865 10.1160.TH12-11-0865 . DOI: 10.1160/TH12-11-0865 http://doi.org/10.1160/TH12-11-0865 http://www.thieme-connect.de/DOI/DOI?10.1160/TH12-11-0865 http://www.thieme-connect.de/DOI/DOI?10.1160/TH12-11-0865

Okata T , Miyata S , Miyashita F , et al . Spontaneous heparin-induced thrombocytopenia syndrome without any proximate heparin exposure, infection, or inflammatory condition: atypical clinical features with heparin-dependent platelet activating antibodies . Platelets 2015 ; 26 ( 6 ): 602 - 7 . doi: 10.3109/09537 104.2014.979338 10.3109.09537 104.2014.979338 . DOI: 10.3109/09537104.2014.979338 http://doi.org/10.3109/09537104.2014.979338 http://www.tandfonline.com/doi/full/10.3109/09537104.2014.979338 http://www.tandfonline.com/doi/full/10.3109/09537104.2014.979338

Bito S , Miyata S , Migita K , et al . Mechanical prophylaxis is a heparin-independent risk for anti-platelet factor 4/heparin antibody formation after orthopedic surgery . Blood 2016 ; 127 ( 8 ): 1036 - 43 . doi: 10.1182/blood-2015-06-651620 10.1182.blood-2015-06-651620 . DOI: 10.1182/blood-2015-06-651620 http://doi.org/10.1182/blood-2015-06-651620 http://www.bloodjournal.org/cgi/doi/10.1182/blood-2015-06-651620 http://www.bloodjournal.org/cgi/doi/10.1182/blood-2015-06-651620

Warkentin TE . Knee replacement and HIT without heparin . Blood 2016 ; 127 ( 8 ): 961 - 2 . doi: 10.1182/blood-2015-12-687665 10.1182.blood-2015-12-687665 . DOI: 10.1182/blood-2015-12-687665 http://doi.org/10.1182/blood-2015-12-687665 http://www.bloodjournal.org/cgi/doi/10.1182/blood-2015-12-687665 http://www.bloodjournal.org/cgi/doi/10.1182/blood-2015-12-687665

Wester JP , Haas FJ , Biesma DH , et al . Thrombosis and hemorrhage in heparin-induced thrombocytopenia in seriously ill patients . Intensive Care Med 2004 ; 30 ( 10 ): 1927 - 34 . doi: 10.1007/s00134-004-2334-1 10.1007.s00134-004-2334-1 . DOI: 10.1007/s00134-004-2334-1 http://doi.org/10.1007/s00134-004-2334-1 http://link.springer.com/10.1007/s00134-004-2334-1 http://link.springer.com/10.1007/s00134-004-2334-1

Arnold DM , NaziI, WarkentinTE , et al . Approach to the diagnosis and management of drug-induced immune thrombocytopenia . Transfus Med Rev 2013 ; 27 ( 3 ): 137 - 45 . doi: 10.1016/j.tmrv.2013.05.005 10.1016.j.tmrv.2013.05.005 . DOI: 10.1016/j.tmrv.2013.05.005 http://doi.org/10.1016/j.tmrv.2013.05.005 https://linkinghub.elsevier.com/retrieve/pii/S0887796313000382 https://linkinghub.elsevier.com/retrieve/pii/S0887796313000382

Tvito A , Bakchoul T , Rowe JM , et al . Severe and persistent heparin-induced thrombocytopenia despite fondaparinux treatment . Am J Hematol 2015 ; 90 ( 7 ): 675 - 8 . doi: 10.1002/ajh.23971 10.1002.ajh.23971 . DOI: 10.1002/ajh.23971 http://doi.org/10.1002/ajh.23971 http://doi.wiley.com/10.1002/ajh.v90.7 http://doi.wiley.com/10.1002/ajh.v90.7

Betrosian AP , Theodossiades G , Balla M , et al . Heparin-induced thrombocytopenia: correction of severe bleeding complication with intravenous immune globulin . Intensive Care Med 2004 ; 30 ( 11 ):2136; author reply 2137. doi: 10.1007/s00134-004-2437-8 10.1007.s00134-004-2437-8 . DOI: 10.1007/s00134-004-2437-8 http://doi.org/10.1007/s00134-004-2437-8 http://link.springer.com/article/10.1007/s00134-004-2437-8 http://link.springer.com/article/10.1007/s00134-004-2437-8

British Committee for Standards in Haematology , Blood Transfusion Task Force . Guidelines for the use of platelet transfusions . Br J Haematol 2003 ; 122 ( 1 ): 10 - 23 . DOI: 10.1046/j.1365-2141.2003.04468.x http://doi.org/10.1046/j.1365-2141.2003.04468.x http://doi.wiley.com/10.1046/j.1365-2141.2003.04468.x http://doi.wiley.com/10.1046/j.1365-2141.2003.04468.x

Goel R , Ness PM , Takemoto CM , et al . Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality . Blood 2015 ; 125 ( 9 ): 1470 - 6 . doi: 10.1182/blood-2014-10-605493 10.1182.blood-2014-10-605493 . DOI: 10.1182/blood-2014-10-605493 http://doi.org/10.1182/blood-2014-10-605493 http://www.bloodjournal.org/cgi/doi/10.1182/blood-2014-10-605493 http://www.bloodjournal.org/cgi/doi/10.1182/blood-2014-10-605493

Cuker A . Management of the multiple phases of heparin-induced thrombocytopenia . Thromb Haemost 2016 ; 116 ( 5 ): 835 - 42 . doi: 10.1160/TH16-02-0084 10.1160.TH16-02-0084 . DOI: 10.1160/TH16-02-0084 http://doi.org/10.1160/TH16-02-0084 http://www.thieme-connect.de/DOI/DOI?10.1160/TH16-02-0084 http://www.thieme-connect.de/DOI/DOI?10.1160/TH16-02-0084

Liang SX , Pinkevych M , Khachigian LM , et al . Drug-induced thrombocytopenia: development of a novel NOD/SCID mouse model to evaluate clearance of circulating platelets by drug-dependent antibodies and the efficacy of IVIG . Blood 2010 ; 116 ( 11 ): 1958 - 60 . doi: 10.1182/blood-2010-02-268326 10.1182.blood-2010-02-268326 . DOI: 10.1182/blood-2010-02-268326 http://doi.org/10.1182/blood-2010-02-268326 http://www.bloodjournal.org/cgi/doi/10.1182/blood-2010-02-268326 http://www.bloodjournal.org/cgi/doi/10.1182/blood-2010-02-268326

Greinacher A . Clinical practice. Heparin-induced thrombocytopenia . N Engl J Med 2015 ; 373 ( 3 ): 252 - 61 . doi: 10.1056/NEJMcp1411910 10.1056.NEJMcp1411910 . DOI: 10.1056/NEJMcp1411910 http://doi.org/10.1056/NEJMcp1411910 http://www.nejm.org/doi/10.1056/NEJMcp1411910 http://www.nejm.org/doi/10.1056/NEJMcp1411910

Linkins LA , Dans AL , Moores LK , et al . Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines . Chest 2012 ; 141 ( 2 Suppl ): e495S - e530S . doi: 10.1378/chest.11-2303 10.1378.chest.11-2303 . DOI: 10.1378/chest.11-2303 http://doi.org/10.1378/chest.11-2303 https://linkinghub.elsevier.com/retrieve/pii/S0012369212601305 https://linkinghub.elsevier.com/retrieve/pii/S0012369212601305

Linkins LA , Warkentin TE , Pai M , et al . Design of the rivaroxaban for heparin-induced thrombocytopenia study . J Thromb Thrombolysis 2014 ; 38 ( 4 ): 485 - 92 . doi: 10.1007/s11239-014-1064-7 10.1007.s11239-014-1064-7 . DOI: 10.1007/s11239-014-1064-7 http://doi.org/10.1007/s11239-014-1064-7 http://link.springer.com/10.1007/s11239-014-1064-7 http://link.springer.com/10.1007/s11239-014-1064-7

Sachais BS , Rux AH , Cines DB , et al . Rational design and characterization of platelet factor 4 antagonists for the study of heparin-induced thrombocytopenia . Blood 2012 ; 119 ( 25 ): 5955 - 62 . doi: 10.1182/blood-2012-01-406801 10.1182.blood-2012-01-406801 . DOI: 10.1182/blood-2012-01-406801 http://doi.org/10.1182/blood-2012-01-406801 http://www.bloodjournal.org/cgi/doi/10.1182/blood-2012-01-406801 http://www.bloodjournal.org/cgi/doi/10.1182/blood-2012-01-406801

浏览量

1193

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

关联资源

暂无数据